Prediction of epidermal growth factor receptor mutation status by textural features in stage IV lung adenocarcinoma

被引:0
|
作者
Wang, Changbin [1 ]
Zhang, Ran [2 ,3 ]
Sun, Xiaorong [4 ]
Xing, Ligang [5 ]
机构
[1] Shengli Oilfield Cent Hosp, Dept Radiat Oncol, Dongying, Shandong, Peoples R China
[2] Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Med, Dept Radiat Oncol, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai, Peoples R China
[4] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Nucl Med, Jinan, Shandong, Peoples R China
[5] Shandong First Med Univ & Shandong Acad Med Sci, Dept Radiat Oncol, Shandong Canc Hosp & Inst, 440 Jiyan Rd, Jinan, Shandong, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Lung neoplasms; Positron emission tomography; Computed tomography; Texture features; Non-small cell lung cancer; EGFR MUTATIONS; CANCER; GEFITINIB; GENE;
D O I
10.1007/s12254-024-00961-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe purpose of this study was to assess the correlation between textural features from 18fluorodeoxyglucose positron emission tomography (18F-FDG-PET) or computed tomography (CT) and EGFR mutation status in patients with stage IV adenocarcinoma lung cancer.MethodsIn all, 71 patients who were diagnosed with stage IV adenocarcinoma lung cancer between April 2014 and August 2018 were included in this study. 18F-FDG-PET/CT scanning and EGFR mutation tests were performed before targeted molecular therapy. Textural features were extracted from manually segmented volumes of tumors, and highly dependent features were excluded. Multivariate logistic regression analysis was used to establish predictive models for detection of EGFR mutations. Receiver operating characteristic (ROC) curves were applied to evaluate areas under the curves (AUCs) of each model.ResultsOf the 71 patients, 39 (54.9%) were EGFR mutation and 32 (45.1%) showed wild-type. EGFR mutation status was significantly associated with female sex (P = 0.026). In multivariate analysis, three PET (co-occurrence contrast, intensity-size-zone low-intensity large-zone emphasis, and texture spectrum max spectrum) and two CT quantitative features (intensity-size-zone high-intensity zone emphasis and normalized co-occurrence second angular moment) were independent predictors of EGFR mutation status. The predictive model generated from combined clinical and textural features showed a better predictive value than the model from textural features alone (AUC 0.897 vs 0.864).ConclusionsTextural features combined with clinical features could establish a model for improving the predicting power of EGFR mutation status in patients with stage IV adenocarcinoma lung cancer.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 50 条
  • [1] Cytomorphological features as predictors of epidermal growth factor receptor mutation status in lung adenocarcinoma
    Sharma, Saniya
    Gupta, Nalini
    Singh, Navneet
    Chaturvedi, Rini
    Behera, Digambar
    Rajwanshi, Arvind
    CYTOJOURNAL, 2018, 15
  • [2] Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features
    Zhu, Huiyuan
    Song, Yueqiang
    Huang, Zike
    Zhang, Lian
    Chen, Yanqing
    Tao, Guangyu
    She, Yunlang
    Sun, Xiwen
    Yu, Hong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (06) : 586 - 594
  • [3] Metabolic Phenotype of Stage IV Lung Adenocarcinoma Relationship With Epidermal Growth Factor Receptor Mutation
    Lee, Elaine Yuen Phin
    Khong, Pek-Lan
    Lee, Victor Ho Fun
    Qian, Wenshu
    Yu, Xue
    Wong, Maria Pik
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (03) : E190 - E195
  • [4] CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma
    Liu, Ying
    Kim, Jongphil
    Qu, Fangyuan
    Liu, Shichang
    Wang, Hua
    Balagurunathan, Yoganand
    Ye, Zhaoxiang
    Gillies, Robert J.
    RADIOLOGY, 2016, 280 (01) : 271 - 280
  • [5] Cytologic features of lung adenocarcinoma with epidermal growth factor receptor mutation
    Nomura, M.
    Hirano, T.
    Ohira, T.
    Kakihana, M.
    Fujioka, K.
    Honda, H.
    Yoshida, K.
    Maeda, J.
    Kato, H.
    ACTA CYTOLOGICA, 2007, 51 (02) : 335 - 336
  • [6] Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma
    Zou, Jiawei
    Lv, Tangfeng
    Zhu, Suhua
    Lu, Zhenfeng
    Shen, Qin
    Xia, Leilei
    Wu, Jie
    Song, Yong
    Liu, Hongbing
    THORACIC CANCER, 2017, 8 (03) : 260 - 270
  • [7] Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns
    Hsu, Kuo-Hsuan
    Chen, Kun-Chieh
    Yang, Tsung-Ying
    Yeh, Yi-Chen
    Chou, Teh-Ying
    Chen, Hsuan-Yu
    Tsai, Chi-Ren
    Chen, Chih-Yi
    Hsu, Chung-Ping
    Hsia, Jiun-Yi
    Chuang, Cheng-Yen
    Tsai, Ying-Huang
    Chen, Kuan-Yu
    Huang, Ming-Shyan
    Su, Wu-Chou
    Chen, Yuh-Min
    Hsiung, Chao A.
    Chang, Gee-Chen
    Chen, Chien-Jen
    Yang, Pan-Chyr
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : 1066 - 1072
  • [8] Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung
    Fukui, Tomoya
    Tsuta, Koji
    Furuta, Koh
    Watanabe, Shun-ichi
    Asamura, Hisao
    Ohe, Yuichiro
    Maeshima, Akiko Miyagi
    Shibata, Tatsuhiro
    Masuda, Noriyuki
    Matsuno, Yoshihiro
    CANCER SCIENCE, 2007, 98 (11) : 1714 - 1719
  • [9] The long-term outcome of epidermal growth factor receptor mutation in stage IV lung adenocarcinoma patients.
    Huang, Chung-Jen
    Chen, Justin
    Feng, An-Chen
    Lin, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma
    Lu, Chao-Wen
    Lin, Mong-Wei
    Chiang, Xu-Heng
    Hsu, Hsao-Hsun
    Hsieh, Min-Shu
    Chen, Jin-Shing
    DIAGNOSTICS, 2023, 13 (03)